A mid-sized regional carrier spends a decade building a respectable book of business, strong loss ratios, loyal agents, a name people in three states recognize. Then a private equity-backed platform offers a premium over book value, and the board has to answer a question that didn’t used to come up this often: is staying independent still the better bet?
That question is showing up in boardrooms across the industry more frequently than it has in years. Insurance M&A deal value climbed to roughly $104 billion in 2025, up from $88 billion in 2024, and the recovery followed a historic downturn the year before that. The number that matters isn’t just the dollar figure. It’s what’s driving carriers of every size to conclude that scale, not just performance, decides who controls their own future.
The Deal Volume Is Climbing Back
2024 was a record low for completed insurance deals, driven by economic and political uncertainty and rising transaction costs. Carriers that might have been shopping for acquisitions instead sat on capital, waiting for clearer signals on rates and regulation. That patience didn’t last.
Deloitte’s 2025 outlook found nine out of ten surveyed insurance companies expected to close more deals than they had the year before, and the same share reported they had either recently restructured or were actively considering it. By early 2026, Clyde & Co’s Insurance Growth Update showed the market stabilizing, with the Asia-Pacific region posting the sharpest rebound in deal count while activity in the Americas cooled slightly from its 2024 peak.
Why Scale Has Become the Deciding Factor
Three pressures are pushing carriers toward the negotiating table rather than the standalone growth plan.
Underwriting Costs Are Outrunning Smaller Balance Sheets
Catastrophic weather events, new liability classes tied to cyber and climate risk, and inflation in claims severity have all made underwriting more capital-intensive. A carrier writing $200 million in premium doesn’t have the same reinsurance leverage or data infrastructure as one writing $2 billion. Scale used to be an advantage. Now, in specialty and excess-and-surplus lines especially, it’s closer to a requirement.
Private Capital Wants In, But Only at Certain Sizes
Private capital in 2026 is expected to concentrate on specialty property and casualty, excess and surplus lines, and managing general agents, where underwriting flexibility and scalable economics make the returns more predictable. That preference reshapes who gets acquired. Sponsors aren’t interested in propping up an undifferentiated regional book. They’re buying platforms they can consolidate, then scale through follow-on acquisitions of exactly the kind of standalone carrier that’s now a target.
Technology Gaps Are Getting More Expensive to Close Alone
Technology-driven M&A in the sector is now concentrated on acquiring AI and analytics capabilities for underwriting, pricing, and claims, rather than broad digital overhauls. Building that capability internally takes years and a technical team most mid-sized carriers don’t have. Buying it, or being bought by a platform that already has it, is often faster and cheaper than the do-it-yourself route.
Who’s Actually Buying, and Why Structuring Matters
The buyer pool has shifted. US-led deal volume has softened somewhat as large brokers continue digesting the acquisitions they made in 2023 and 2024, while carriers in Europe have stepped up domestic and cross-border acquisitions to address rising costs, new regulatory requirements, and the need for scale. That’s a meaningful shift: the deals of the past few years were dominated by brokers buying agencies. The next wave looks more like carrier-to-carrier consolidation, and those transactions carry a different risk profile entirely.
A broker acquisition is mostly a client-book valuation exercise. A carrier acquisition means absorbing reserves, reinsurance treaties, regulatory capital requirements across every state the target is licensed in, and loss development patterns that won’t fully reveal themselves for years. Getting the valuation wrong on the reserve side doesn’t show up as a bad quarter. It shows up as a multi-year drag on the combined entity’s capital position.
That’s the layer most sellers underestimate going in. Much of this activity runs through firms specializing in insurance investment banking, who structure the valuations and deal terms behind these acquisitions, precisely because generalist M&A advisors rarely have the actuarial fluency to price a book of long-tail liability correctly. A carrier that walks into a sale process without that kind of specialized advisory support is negotiating from a position it doesn’t fully understand.
What This Means for Carriers Weighing Their Options
Not every insurer needs to sell, and not every consolidation wave rewards the sellers who move first. But the carriers making the clearest-eyed decisions right now share a pattern: they’re running the acquisition math on themselves before a buyer does it for them. That means an honest look at three things:
- Whether current reinsurance capacity and cost structure can support growth at the pace competitors are now moving
- Whether the technology stack can absorb AI-driven underwriting and claims tools without a multi-year rebuild
- Whether the balance sheet can weather a hard market cycle without needing capital from a buyer on unfavorable terms
A carrier that answers those questions honestly, and starts the conversation with an advisor before a suitor does, tends to end up on better terms whichever path it chooses. The ones caught flat-footed are the ones who find out their independence was never as secure as they assumed.
Leave a Reply